shRNA knockdown of CDK12 in DM1 cells produced a decrease in the amount of nuclear foci and CDK12 granules by 69% and 56%, respectively, whereas CDK12 overexpression in the DM1 cells resulted in increased numbers of nuclear foci [7]. The gene discussed is CDK12; the disease is myotonic dystrophy type 1.